JP Stock MarketDetailed Quotes

4564 OncoTherapy Science

Watchlist

32
00.00%

20min DelayMarket Closed Nov 8 15:30 JST

8.69BMarket Cap-5289P/E (Static)

OncoTherapy Science Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

Total revenue

-46.24%610.12M

-66.89%144.11M

-40.82%109.55M

61.66%208.32M

-61.59%148.14M

-1.63%1.13B

-46.82%435.21M

95.68%185.12M

-12.59%128.86M

313.92%385.7M

Cost of revenue

-27.93%787.84M

-51.55%183M

-21.64%159.99M

48.20%254.95M

-44.03%189.9M

5.14%1.09B

-46.32%377.75M

74.30%204.18M

20.97%172.04M

342.40%339.26M

Gross profit

-526.34%-177.72M

-167.67%-38.89M

-164.71%-50.44M

-8.02%-46.63M

-189.92%-41.76M

-63.41%41.69M

-49.91%57.47M

15.46%-19.05M

-928.00%-43.17M

181.52%46.44M

Operating expense

-17.86%943.08M

-57.84%109.16M

-15.03%227.56M

-2.12%261.88M

-2.63%344.49M

-47.01%1.15B

-43.35%258.94M

-63.76%267.82M

-30.04%267.55M

-39.83%353.79M

Selling and administrative expenses

-38.60%265.03M

-129.05%-30.3M

-14.06%94.73M

-6.54%90.58M

-8.47%110.02M

-1.06%431.64M

-2.96%104.3M

3.84%110.22M

-5.44%96.92M

0.03%120.2M

-General and administrative expense

-38.60%265.03M

-129.05%-30.3M

-14.06%94.73M

-6.54%90.58M

-8.47%110.02M

-1.06%431.64M

-2.96%104.3M

3.84%110.22M

-5.44%96.92M

0.03%120.2M

Research and development costs

-5.36%678.05M

-9.82%139.46M

-15.71%132.83M

0.38%171.29M

0.38%234.47M

-58.59%716.46M

-55.76%154.64M

-75.10%157.59M

-39.05%170.64M

-50.07%233.59M

Operating profit

-1.30%-1.12B

26.52%-148.05M

3.09%-277.99M

0.71%-308.51M

-25.67%-386.25M

46.10%-1.11B

41.15%-201.47M

62.33%-286.87M

17.63%-310.73M

46.22%-307.35M

Net non-operating interest income (expenses)

-324.36%-9.9M

91.45%-218K

-1,029.77%-1.22M

-1,078.16%-851K

-7.61M

56.59%-2.33M

-180.53%-2.55M

106.78%131K

103.54%87K

Non-operating interest income

-91.28%19K

--0

----

-49.30%218K

--0

-57.74%131K

----

Non-operating interest expense

--218K

----

--0

----

Total other finance cost

280.27%9.7M

--0

--1.22M

--870K

--7.61M

-56.05%2.55M

----

Net investment income

33.52%-5.68M

-212.95%-1.67M

-31.93%957K

40.81%-1.59M

49.78%-3.39M

40.58%-8.55M

92.45%-533K

122.75%1.41M

-221.85%-2.68M

-2,095.44%-6.74M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

-995.43%-149.34M

-22,033.58%-150.29M

116.35%2.2M

122.21%1.38M

-107.10%-2.63M

103.35%16.68M

99.18%-679K

90.34%-13.46M

98.03%-6.19M

0.37%37M

Less:Other special charges

86.33%-5.23M

-246.64%-1.65M

---2.2M

----

22.37%-38.23M

---476K

--0

21.18%-37.76M

Less:Write off

617.13%154.56M

13,054.72%151.94M

--0

249.80%2.63M

-96.07%21.55M

-98.60%1.16M

-90.43%13.46M

-98.03%6.19M

-93.19%751K

Other non-operating income (expenses)

100.04%6K

-2,686.58%-15.8M

60.81%357K

Income before tax

-15.16%-1.29B

-46.54%-300.22M

7.61%-276.05M

7.78%-309.57M

-44.31%-399.87M

56.56%-1.12B

52.62%-204.87M

67.13%-298.79M

51.65%-335.67M

48.17%-277.09M

Income tax

9.09%2.43M

2.26%588K

-0.16%612K

88.62%613K

-13.80%612K

80.15%2.22M

760.92%575K

18.34%613K

-37.38%325K

150.00%710K

Net income

-15.15%-1.29B

-46.42%-300.81M

7.59%-276.67M

7.68%-310.18M

-44.16%-400.49M

56.50%-1.12B

52.48%-205.45M

67.08%-299.4M

51.64%-336M

48.07%-277.8M

Net income continuous operations

-15.15%-1.29B

-46.42%-300.81M

7.59%-276.67M

7.68%-310.18M

-44.16%-400.49M

56.50%-1.12B

52.48%-205.45M

67.08%-299.4M

51.64%-336M

48.07%-277.8M

Noncontrolling interests

Net income attributable to the company

-15.15%-1.29B

-46.42%-300.81M

7.59%-276.67M

7.68%-310.18M

-44.16%-400.49M

56.50%-1.12B

52.48%-205.45M

67.08%-299.4M

51.64%-336M

48.07%-277.8M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-15.15%-1.29B

-46.42%-300.81M

7.59%-276.67M

7.68%-310.18M

-44.16%-400.49M

56.50%-1.12B

52.48%-205.45M

67.08%-299.4M

51.64%-336M

48.07%-277.8M

Gross dividend payment

Basic earnings per share

-4.13%-6.05

-28.04%-1.37

18.71%-1.26

18.29%-1.43

-38.19%-1.99

57.65%-5.81

51.36%-1.07

67.57%-1.55

53.21%-1.75

52.00%-1.44

Diluted earnings per share

-4.13%-6.05

-29.17%-1.3821

18.21%-1.2712

18.29%-1.43

-38.19%-1.99

57.65%-5.81

52.32%-1.07

67.49%-1.5542

53.21%-1.75

52.00%-1.44

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022
Total revenue	-46.24%610.12M	-66.89%144.11M	-40.82%109.55M	61.66%208.32M	-61.59%148.14M	-1.63%1.13B	-46.82%435.21M	95.68%185.12M	-12.59%128.86M	313.92%385.7M
Cost of revenue	-27.93%787.84M	-51.55%183M	-21.64%159.99M	48.20%254.95M	-44.03%189.9M	5.14%1.09B	-46.32%377.75M	74.30%204.18M	20.97%172.04M	342.40%339.26M
Gross profit	-526.34%-177.72M	-167.67%-38.89M	-164.71%-50.44M	-8.02%-46.63M	-189.92%-41.76M	-63.41%41.69M	-49.91%57.47M	15.46%-19.05M	-928.00%-43.17M	181.52%46.44M
Operating expense	-17.86%943.08M	-57.84%109.16M	-15.03%227.56M	-2.12%261.88M	-2.63%344.49M	-47.01%1.15B	-43.35%258.94M	-63.76%267.82M	-30.04%267.55M	-39.83%353.79M
Selling and administrative expenses	-38.60%265.03M	-129.05%-30.3M	-14.06%94.73M	-6.54%90.58M	-8.47%110.02M	-1.06%431.64M	-2.96%104.3M	3.84%110.22M	-5.44%96.92M	0.03%120.2M
-General and administrative expense	-38.60%265.03M	-129.05%-30.3M	-14.06%94.73M	-6.54%90.58M	-8.47%110.02M	-1.06%431.64M	-2.96%104.3M	3.84%110.22M	-5.44%96.92M	0.03%120.2M
Research and development costs	-5.36%678.05M	-9.82%139.46M	-15.71%132.83M	0.38%171.29M	0.38%234.47M	-58.59%716.46M	-55.76%154.64M	-75.10%157.59M	-39.05%170.64M	-50.07%233.59M
Operating profit	-1.30%-1.12B	26.52%-148.05M	3.09%-277.99M	0.71%-308.51M	-25.67%-386.25M	46.10%-1.11B	41.15%-201.47M	62.33%-286.87M	17.63%-310.73M	46.22%-307.35M
Net non-operating interest income (expenses)	-324.36%-9.9M	91.45%-218K	-1,029.77%-1.22M	-1,078.16%-851K	-7.61M	56.59%-2.33M	-180.53%-2.55M	106.78%131K	103.54%87K	0
Non-operating interest income	-91.28%19K	--0	--0	----	----	-49.30%218K	--0	-57.74%131K	----	----
Non-operating interest expense	--218K	----	----	----	----	--0	----	----	----	----
Total other finance cost	280.27%9.7M	--0	--1.22M	--870K	--7.61M	-56.05%2.55M	----	----	----	----
Net investment income	33.52%-5.68M	-212.95%-1.67M	-31.93%957K	40.81%-1.59M	49.78%-3.39M	40.58%-8.55M	92.45%-533K	122.75%1.41M	-221.85%-2.68M	-2,095.44%-6.74M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	-995.43%-149.34M	-22,033.58%-150.29M	116.35%2.2M	122.21%1.38M	-107.10%-2.63M	103.35%16.68M	99.18%-679K	90.34%-13.46M	98.03%-6.19M	0.37%37M
Less:Other special charges	86.33%-5.23M	-246.64%-1.65M	---2.2M	----	----	22.37%-38.23M	---476K	--0	--0	21.18%-37.76M
Less:Write off	617.13%154.56M	13,054.72%151.94M	--0	--0	249.80%2.63M	-96.07%21.55M	-98.60%1.16M	-90.43%13.46M	-98.03%6.19M	-93.19%751K
Other non-operating income (expenses)	100.04%6K	0	0			-2,686.58%-15.8M	60.81%357K	0
Income before tax	-15.16%-1.29B	-46.54%-300.22M	7.61%-276.05M	7.78%-309.57M	-44.31%-399.87M	56.56%-1.12B	52.62%-204.87M	67.13%-298.79M	51.65%-335.67M	48.17%-277.09M
Income tax	9.09%2.43M	2.26%588K	-0.16%612K	88.62%613K	-13.80%612K	80.15%2.22M	760.92%575K	18.34%613K	-37.38%325K	150.00%710K
Net income	-15.15%-1.29B	-46.42%-300.81M	7.59%-276.67M	7.68%-310.18M	-44.16%-400.49M	56.50%-1.12B	52.48%-205.45M	67.08%-299.4M	51.64%-336M	48.07%-277.8M
Net income continuous operations	-15.15%-1.29B	-46.42%-300.81M	7.59%-276.67M	7.68%-310.18M	-44.16%-400.49M	56.50%-1.12B	52.48%-205.45M	67.08%-299.4M	51.64%-336M	48.07%-277.8M
Noncontrolling interests
Net income attributable to the company	-15.15%-1.29B	-46.42%-300.81M	7.59%-276.67M	7.68%-310.18M	-44.16%-400.49M	56.50%-1.12B	52.48%-205.45M	67.08%-299.4M	51.64%-336M	48.07%-277.8M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-15.15%-1.29B	-46.42%-300.81M	7.59%-276.67M	7.68%-310.18M	-44.16%-400.49M	56.50%-1.12B	52.48%-205.45M	67.08%-299.4M	51.64%-336M	48.07%-277.8M
Gross dividend payment
Basic earnings per share	-4.13%-6.05	-28.04%-1.37	18.71%-1.26	18.29%-1.43	-38.19%-1.99	57.65%-5.81	51.36%-1.07	67.57%-1.55	53.21%-1.75	52.00%-1.44
Diluted earnings per share	-4.13%-6.05	-29.17%-1.3821	18.21%-1.2712	18.29%-1.43	-38.19%-1.99	57.65%-5.81	52.32%-1.07	67.49%-1.5542	53.21%-1.75	52.00%-1.44
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data